Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Meghana Malkan of malkansview.com recommends selling Crompton Greaves with a target of Rs 121 and advises buying Ashok Leyland with a target of Rs 18.50.
Meghana Malkan of malkansview.com advises buying Ashok Leyland for a target price of Rs 18.50 and Arvind for a target price of Rs 152.
Kunal Bothra of LKP recommends buying Den Networks with a target of Rs 169 and suggets buying Arvind.
Meghana Malkan of malkansview.com recommends buying Aditya Birla Nuvo with a target of Rs 1275 and advises seling Adani Enterprises with a target of Rs 254.
Rakesh Gandhi, independent technical analyst recommends buying Dishman Pharmaceuticals & Chemicals with a target of Rs 104.50 and Arvind with a target of Rs 141.75.
According to Rakesh Gandhi, Independent Technical Analyst, one may buy Arvind for a target price of Rs 136 and Tata Global Beverage for a target price of Rs 162.
Dharmesh Kant of Indianivesh Securities recommends buying UPL for a target of Rs 200 and Tata Global Beverage for a target of Rs 170.
Dharmesh Kant of Indianivesh Securities suggests buying Arvind for a target price of Rs 145 and Federal Bank for a target price of Rs 90.
Pankaj Jain of Sunteck Wealthmax advises buying Apollo Hospital for a target price of Rs 907 and Apollo Tyres for a target price of Rs 108.
SP Tulsian of sptulsian.com is of the view that Arvind may test Rs 140. "One could see the level of Rs 126 to Rs 130 which can be the entry point again at that level," he adds.
Sudarshan Sukhani of s2analytics.com recommends buying Arvind on dips.
Dharmesh Kant of Indianivesh Securities recommends buying Alembic Pharmaceuticals with a target of Rs 220 and Arvind with a target of Rs 136.
Pankaj Jain of Sunteck Wealthmax recommends buying GMR Infrastructure with a target of Rs 24.95 and Peninsula Land with a target of Rs 43.45.
SP Tulsian of sptulsian.com advises going long in Arvind at current level.
Shahina Mukadam of Varun Capital recommends buying Tata Motors (DVR) with a target of Rs 196 and advises selling Arvind with a target of Rs 116.
Shahina Mukadam of Varun Capital recommends buying Tata Motors (DVR) with a target of Rs 196 and Allahabad Bank with a target of Rs 86.
Vishal Malkan of malkansview.com recommends buying JSW Energy with a target of Rs 57 and Reliance Infrastructure with a target of Rs 455.
Nooresh Merani of Analyse India advises buying Mcleod Russel for a target price of Rs 320 and Bata India for a target price of Rs 1,080.
Nooresh Merani of Analyse India advises buying NALCO for a target price of Rs 43 and Chambal Fertiliser for a target price of Rs 42.
Dharmesh Kant of India Nivesh Securities recommends buying Bank of India with a target of Rs 230 and Aurobindo Pharma with a target of Rs 320.
Dharmesh Kant of India Nivesh Securities advises buying Bank of India for a target price of Rs 230 and Aurobindo Pharma for a target price of Rs 320.
Manas Jaiswal of manasjaiswal.com suggests buying Oriental Bank of Commerce (OBC) with a target of Rs 199 and Arvind with a target of Rs 137.
Nooresh Merani of AMSEC is of the view that one may enter Arvind at around Rs 115-120.
SP Tulsian of sptulsian.com is of the view that Arvind may slip to Rs 118-119 till November expiry.
Vikrant Jadeja of Vibrant Trades suggests selling Arvind with a target of Rs 117 and buying Mcleod Russel (India) with a target of Rs 295-300.